FDA ADVERSE EVENT REPORTING FOR PHARMACEUTICALS 2011 is a course that covers categories such as:
The Concepts of Seriousness, Expectedness and Causality
Adverse Event Reporting to the FDA
Safety Issues and Reporting Obligations
Describe, Characterize and Document Adverse Events
Identify Key Concepts Related to Electronic Records
Associated with Clinical Trials and Marketed Products
The Evolving Role of the FDA in Drug and Biologic Development
FDA ADVERSE EVENT REPORTING FOR PHARMACEUTICALS brings together clinical personnel, Safety personnel, Regulatory personnel, Safety personnel and Quality personnel.
Past Events
FDA ADVERSE EVENT REPORTING FOR PHARMACEUTICALS 2011 - 12-13 Oct 2011, The Rembrandt Hotel, London, United Kingdom (17468)
FDA ADVERSE EVENT REPORTING FOR PHARMACEUTICALS 2026
Important
Please, check "FDA ADVERSE EVENT REPORTING FOR PHARMACEUTICALS" official website for possible changes, before making any traveling arrangements
